These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 8617952
1. Expression and characterization of functionally active recombinant perforin produced in insect cells. Liu CC, Persechini PM, Young JD. J Immunol; 1996 May 01; 156(9):3292-300. PubMed ID: 8617952 [Abstract] [Full Text] [Related]
2. Characterization of recombinant mouse perforin expressed in insect cells using the baculovirus system. Liu CC, Persechini PM, Young JD. Biochem Biophys Res Commun; 1994 May 30; 201(1):318-25. PubMed ID: 8198590 [Abstract] [Full Text] [Related]
4. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. Oshimi Y, Oda S, Honda Y, Nagata S, Miyazaki S. J Immunol; 1996 Oct 01; 157(7):2909-15. PubMed ID: 8816396 [Abstract] [Full Text] [Related]
5. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes. Ye W, Young JD, Liu CC. Cell Immunol; 1996 Nov 25; 174(1):54-62. PubMed ID: 8929454 [Abstract] [Full Text] [Related]
9. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin. Brahmi Z, Csipo I, Bochan MR, Su B, Montel AH, Morse PA. Nat Immun; 1995 Sep 25; 14(5-6):271-85. PubMed ID: 8933821 [Abstract] [Full Text] [Related]
10. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity. Makrigiannis AP, Hoskin DW. J Immunol; 1997 Nov 15; 159(10):4700-7. PubMed ID: 9366393 [Abstract] [Full Text] [Related]
11. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K. J Immunol; 1996 May 15; 156(10):3678-86. PubMed ID: 8621902 [Abstract] [Full Text] [Related]
12. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells. Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, Jocham D, Flad HD, Böhle A. Clin Cancer Res; 2000 Sep 15; 6(9):3729-38. PubMed ID: 10999767 [Abstract] [Full Text] [Related]
16. Purification and characterization of lymphocyte chymase I, a granzyme implicated in perforin-mediated lysis. Woodard SL, Fraser SA, Winkler U, Jackson DS, Kam CM, Powers JC, Hudig D. J Immunol; 1998 May 15; 160(10):4988-93. PubMed ID: 9590247 [Abstract] [Full Text] [Related]
17. Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II. Drechsler A, Potrich C, Sabo JK, Frisanco M, Guella G, Dalla Serra M, Anderluh G, Separovic F, Norton RS. Biochemistry; 2006 Feb 14; 45(6):1818-28. PubMed ID: 16460028 [Abstract] [Full Text] [Related]
18. Homology of perforin to the ninth component of complement (C9). Shinkai Y, Takio K, Okumura K. Nature; 1988 Aug 11; 334(6182):525-7. PubMed ID: 3261391 [Abstract] [Full Text] [Related]
19. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM. Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295 [Abstract] [Full Text] [Related]
20. Expression and bioactivity of recombinant segments of human perforin. Dong H, Xu X, Deng M, Yu X, Zhao H, Song H, Geng Y. Biochem Cell Biol; 2007 Apr 01; 85(2):203-8. PubMed ID: 17534401 [Abstract] [Full Text] [Related] Page: [Next] [New Search]